Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL: A sub‐analysis of the Titration and OPtimisation (TOP) registry

Martin Pfohl; Stefan Pscherer; Andreas Fritsche; Helmut Anderten; Anja Borck; Katrin Pegelow; Peter Bramlage; Jochen Seufert

doi:10.1111/dom.13768

Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL: A sub‐analysis of the Titration and OPtimisation (TOP) registry

Diabetes Obesity and Metabolism ◽

10.1111/dom.13768 ◽

2019 ◽

Vol 21 (9) ◽

pp. 2169-2173 ◽

Cited By ~ 2

Author(s):

Martin Pfohl ◽

Stefan Pscherer ◽

Andreas Fritsche ◽

Helmut Anderten ◽

Anja Borck ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Review for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"

10.1111/dom.13768/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Review for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"

10.1111/dom.13768/v1/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Decision letter for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"

10.1111/dom.13768/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Decision letter for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"

10.1111/dom.13768/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Review for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"

10.1111/dom.13768/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Author response for "Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL – a sub‐analysis of the Titration and OPtimisation (TOP) registry"

10.1111/dom.13768/v2/response1 ◽

2019 ◽

Author(s):

Martin Pfohl ◽

Stefan Pscherer ◽

Andreas Fritsche ◽

Helmut Anderten ◽

Anja Borck ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Response ◽

Oral Therapy ◽

Author Response ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2014.09.012 ◽

2015 ◽

Vol 29 (1) ◽

pp. 127-133 ◽

Cited By ~ 5

Author(s):

Masato Odawara ◽

Takashi Kadowaki ◽

Yusuke Naito

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Oral Therapy ◽

Microvascular Complications ◽

Hypoglycemic Agents ◽

Oral Hypoglycemic Agents ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Efficacy and Safety of Patient-Led Dosage Adjustments of Insulin Glargine: A Preliminary Report of Basal-Supported Oral Therapy for Japanese Type 2 Diabetes Patients

Journal of Diabetes Mellitus ◽

10.4236/jdm.2014.42014 ◽

2014 ◽

Vol 04 (02) ◽

pp. 77-84

Author(s):

Shuhei Nakanishi ◽

Mitsunobu Kubota ◽

Rui Kishimoto

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Preliminary Report ◽

Oral Therapy ◽

Efficacy And Safety ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

Value in Health ◽

10.1016/j.jval.2016.09.1841 ◽

2016 ◽

Vol 19 (7) ◽

pp. A666-A667

Author(s):

B Ehlken ◽

K Kostev

Keyword(s):

Type 2 Diabetes ◽

Primary Care ◽

Treatment Outcomes ◽

Oral Therapy ◽

Care Practices ◽

Primary Care Practices ◽

Basal Supported Oral Therapy ◽

Diabetes Patients

Download Full-text

Predictors for achieving target glycemic control in Japanese patients with type 2 diabetes after initiation of basal supported oral therapy using insulin glargine: sub-analysis of the ALOHA2 study, drug use surveillance in Japan

Diabetology International ◽

10.1007/s13340-015-0236-9 ◽

2015 ◽

Vol 7 (2) ◽

pp. 188-198 ◽

Cited By ~ 3

Author(s):

Yukio Ikeda ◽

Shoko Tsukube ◽

Takashi Kadowaki ◽

Masato Odawara

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Drug Use ◽

Insulin Glargine ◽

Oral Therapy ◽

Study Drug ◽

Japanese Patients ◽

Basal Supported Oral Therapy

Download Full-text